Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gynecologic 1Genitourinary 1Gastrointestinal 1CNS 1

Conditions

Testicular Neoplasms 2Teratoma 1Seminoma 1Sarcoma 1Ovarian Neoplasms 1Ovarian Germ Cell Cancer 1Ototoxicity 1Osteosarcoma 1Neuroblastoma 1Medulloblastoma 1Liver Neoplasms 1Hepatoblastoma 1Hearing Loss 1Central Nervous System Neoplasms 1Brain Neoplasms 1

Interventions

Filgrastim 9Cyclophosphamide 9X-Rays 7Phantoms, Imaging 7Specimen Handling 6Magnetic Resonance Spectroscopy 6Flow Cytometry 6Carboplatin 6Temozolomide 5Nuclear Medicine Department, Hospital 5Melphalan 5Granulocyte Colony-Stimulating Factor 5Busulfan 5Biopsy 5Therapeutics 4Polymerase Chain Reaction 4Peripheral Blood Stem Cell Transplantation 4Etoposide 4Amplified Fragment Length Polymorphism Analysis 4fludarabine 3Vincristine 3Topotecan 3Thiotepa 3Stem Cell Transplantation 3Psychiatric Rehabilitation 3Methylprednisolone 3Itraconazole 3Irinotecan 3Ipilimumab 3Immunologic Techniques 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neuroblastoma × sodium thiosulfate × Genitourinary × Clear all
NCT00716976 2023-11-09

Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy

Children's Oncology Group

Phase 3 Completed
131 enrolled 18 charts 1 FDA
CNSGastrointestinalGenitourinaryGynecologicSarcoma

Ovarian Germ Cell Cancer, Ototoxicity, Brain Neoplasms, Liver Neoplasms, Medulloblastoma, Neuroblastoma, Ovarian Neoplasms, Sarcoma, Osteosarcoma, Teratoma, Testicular Neoplasms, Central Nervous System Neoplasms, Hepatoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡